At two parallel conferences, experts from the pharmaceutical and biotechnology industries joined together to explore ongoing challenges in the drug development sector and offer practical solutions.

A large-scale analysis of millions of cancer studies has uncovered patterns suggesting that a significant portion of the literature may not be as reliable as it appears.

Ensemble integrating three architectures achieved area under the curve of 0.9208, outperforming individual models.

A new AI foundation model from Mass General Brigham may be capable of analyzing brain MRI datasets and predict various ...

Mass General Brigham investigators have developed a robust new artificial intelligence (AI) foundation model that is capable ...

When scientists sequence tumor DNA, they typically find small amounts of genetic code from bacteria, viruses and fungi – microorganisms that, if actually present in tumor tissues, could influence how ...

Kivo reports AI accelerates cancer research by analyzing large datasets, improving clinical trial matching, and expediting ...